Yungin forges strategic tie-up with Novacell

Published: 2012-10-24 06:56:00

Updated: 2012-10-24 06:56:00

Yungjin Pharmaceutical said Monday that it has forged a strategic alliance with Novacell Technology in an effort to develop new proteomix based biomarkers.

The deal with Novacell is expected to help enhance cooperation in the use of patents and technologies in the latest biomarkers that will b...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK